Replies to post #220926 on Biotech Values

[DewDiligence]

ABBV dumps PRNB’s immunoproteasome program:

https://www.globenewswire.com/news-release/2019/03/11/1751122/0/en/Principia-Biopharma-Reacquires-Rights-to-Oral-Immunoproteasome-Program.html

[DewDiligence]

SNY acquires PRNB @$100/sh in cash—a 10% premium to Friday’s closing price:

https://www.globenewswire.com/news-release/2020/08/17/2078993/0/en/Sanofi-to-acquire-Principia-Biopharma.html

The deal’s enterprise value (excluding PRNB’s cash in hand) is $3.36B.